Background: Coronavirus disease 2019 (COVID-19) is an emerging infectious disease worldwide. Obesity has been proven to increase the susceptibility of an individual to infections, but the relationship between obesity and COVID-19 is still unclear. This study aimed to conduct a systematic review and meta-analysis of the prevalence of obesity and its effects in patients with COVID-19. Methods: Web of Science, PubMed and Embase were searched for English language studies up to May 22, 2020. We used a random or fixed-effects model to calculate pooled prevalence rates and odds ratio (OR) with 95% confidence intervals (CI). Results: Twelve studies with a total of 14 364 patients met the inclusion criteria. The pooled prevalence of obesity in patients with COVID-19 was 32.0% (95% CI, 26%-38%, P < .001). The prevalence of obesity in ICU COVID-19 patients were 37.0% (95% CI, 29%-46%, P < .001). Comparing between obese and non-obese patients, the meta-analysis showed that obesity was an important risk factor associated with COVID-19 patients needed for ICU care (OR: 1.36, 95% CI 1.22-1.52, P < .001). Conclusion: Obesity was highly prevalent (32.0%) in patients with COVID-19, especially in ICU patients (37.0%), and was an important risk factor for COVID-19 patients needed for ICU care.
de GrootRJBakerSCBaricRS, et al. Commentary: middle east respiratory syndrome coronavirus (MERS-CoV): announcement of the coronavirus study group. J Virol. 2013;87:7790-7792.
2.
RastogiMPandeyNShuklaASinghSK.SARS coronavirus 2: from genome to infectome. Respir Res. 2020;21:318-415.
3.
GrasselliGZangrilloAZanellaA, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574-1581.
4.
HuangCWangYLiX, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.
5.
WuZMcGooganJM.Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239-1242.
6.
RichardsonSHirschJSNarasimhanM, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323:2052-2059.
7.
ChenNZhouMDongX, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507-513.
8.
ZhouFYuTDuR, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-1062.
9.
YangJZhengYGouX, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91-95.
10.
HegdeVDhurandharNV.Microbes and obesity–interrelationship between infection, adipose tissue and the immune system. Clin Microbiol Infect. 2013;19:314-320.
11.
KarlssonEABeckMA.The burden of obesity on infectious disease. Exp Biol Med. 2010;235:1412-1424.
12.
KalligerosMShehadehFMylonaEK, et al. Association of obesity with disease severity among patients with coronavirus disease 2019. Obesity. 2020;28:1200-1204.
13.
SimonnetAChetbounMPoissyJ, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity. 2020;28:1195-1199.
14.
BuscemiSBuscemiCBatsisJA.There is a relationship between obesity and coronavirus disease 2019 but more information is needed. Obesity. 2020;28:1371-1373.
15.
TamaraATahaparyDL.Obesity as a predictor for a poor prognosis of COVID-19: a systematic review. Diabetes Metab Syndr Clin Res Rev. 2020;14:655-659.
16.
StroupDFBerlinJAMortonSC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012.
17.
TanK.Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-163.
18.
AlqahtaniJSOyeladeTAldhahirAM, et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS One. 2020;15:1-13.
19.
AggarwalSGarcia-TellesNAggarwalG, et al. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): early report from the United States. Diagnosis. 2020;7:91-96.
20.
CaiQChenFWangT, et al. Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Diabetes Care. 2020;43:1392-1398.
21.
ChaoJYDerespinaKRHeroldBC, et al. Clinical characteristics and outcomes of hospitalized and critically ill children and adolescents with coronavirus disease 2019 at a tertiary care medical center in New York City. J Pediatr. 2020;223:14-19.e2.
22.
GoyalPChoiJJPinheiroLC, et al. Clinical characteristics of Covid-19 in New York city. N Engl J Med. 2020;382:2372-2374.
23.
LighterJPhillipsMHochmanS, et al. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission. Clin Infect Dis. 2020;71:896-897.
24.
McMichaelTMCurrieDWClarkS, et al. Epidemiology of COVID-19 in a long-term care facility in King County, Washington. N Engl J Med. 2020;382:2005-2011.
25.
PetrilliCMJonesSAYangJ, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369.
26.
PivaSFilippiniMTurlaF, et al. Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy. J Crit Care. 2020;58:29-33.
27.
ShekerdemianLSMahmoodNRWolfeKK, et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr. 2020;174:868-873.
28.
Muc Da EncarnacaoMCollaborationNRF. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390:2627-2642.
29.
OsbornOOlefskyJM.The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med. 2012;18:363-374.
30.
CanadellLMartín-LoechesIDíazE, et al. Degree of adherence to recommended antiviral treatment during the pandemic and post-pandemic periods of influenza A(H1N1)pdm09 in 148 intensive care units in Spain. Med Intensiva. 2015;39:222-233.
31.
ZhaoXGangXHeG, et al. Obesity increases the severity and mortality of influenza and COVID-19: a systematic review and meta-analysis. Front Endocrinol. 2020;11: 595109.
32.
MoserJSGalindo-FragaAOrtiz-HernándezAA, et al. Underweight, overweight, and obesity as independent risk factors for hospitalization in adults and children from influenza and other respiratory viruses. Influenza Other Respi Viruses. 2019;13:3-9.
33.
ZhengZPengFXuB, et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81:e16-e25.
34.
MorganOWBramleyAFowlkesA, et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS One. 2010;5: e9694.
